280 related articles for article (PubMed ID: 31799702)
1. Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals.
Williamson EM; Liu X; Izzo AA
Br J Pharmacol; 2020 Mar; 177(6):1227-1240. PubMed ID: 31799702
[TBL] [Abstract][Full Text] [Related]
2. Highlights into the pharmacology of nutraceuticals.
Andrew R; Izzo AA
Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
[TBL] [Abstract][Full Text] [Related]
3. Dietary antioxidants remodel DNA methylation patterns in chronic disease.
Beetch M; Harandi-Zadeh S; Shen K; Lubecka K; Kitts DD; O'Hagan HM; Stefanska B
Br J Pharmacol; 2020 Mar; 177(6):1382-1408. PubMed ID: 31626338
[TBL] [Abstract][Full Text] [Related]
4. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing.
Howes MR; Perry NSL; Vásquez-Londoño C; Perry EK
Br J Pharmacol; 2020 Mar; 177(6):1294-1315. PubMed ID: 31650528
[TBL] [Abstract][Full Text] [Related]
5. Carotenoids: biochemistry, pharmacology and treatment.
Milani A; Basirnejad M; Shahbazi S; Bolhassani A
Br J Pharmacol; 2017 Jun; 174(11):1290-1324. PubMed ID: 27638711
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological basis and new insights of resveratrol action in the cardiovascular system.
Cheng CK; Luo JY; Lau CW; Chen ZY; Tian XY; Huang Y
Br J Pharmacol; 2020 Mar; 177(6):1258-1277. PubMed ID: 31347157
[TBL] [Abstract][Full Text] [Related]
7. The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols.
Man AWC; Xia N; Daiber A; Li H
Br J Pharmacol; 2020 Mar; 177(6):1278-1293. PubMed ID: 31465555
[TBL] [Abstract][Full Text] [Related]
8. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence.
Lin SR; Chang CH; Hsu CF; Tsai MJ; Cheng H; Leong MK; Sung PJ; Chen JC; Weng CF
Br J Pharmacol; 2020 Mar; 177(6):1409-1423. PubMed ID: 31368509
[TBL] [Abstract][Full Text] [Related]
9. Principles of pharmacological research of nutraceuticals.
Andrew R; Izzo AA
Br J Pharmacol; 2017 Jun; 174(11):1177-1194. PubMed ID: 28500635
[TBL] [Abstract][Full Text] [Related]
10. Nutraceuticals as modulators of gut microbiota: Role in therapy.
Quigley EMM
Br J Pharmacol; 2020 Mar; 177(6):1351-1362. PubMed ID: 31659751
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.
Petrosino S; Di Marzo V
Br J Pharmacol; 2017 Jun; 174(11):1349-1365. PubMed ID: 27539936
[TBL] [Abstract][Full Text] [Related]
12. Microbiota-dependent and -independent effects of dietary fibre on human health.
Cai Y; Folkerts J; Folkerts G; Maurer M; Braber S
Br J Pharmacol; 2020 Mar; 177(6):1363-1381. PubMed ID: 31663129
[TBL] [Abstract][Full Text] [Related]
13. Nutraceuticals in hypercholesterolaemia: an overview.
Santini A; Novellino E
Br J Pharmacol; 2017 Jun; 174(11):1450-1463. PubMed ID: 27685833
[TBL] [Abstract][Full Text] [Related]
14. From primordial gas to the medicine cabinet.
Papapetropoulos A; Wallace JL; Wang R
Br J Pharmacol; 2020 Feb; 177(4):715-719. PubMed ID: 31726475
[TBL] [Abstract][Full Text] [Related]
15. Emerging areas of opioid pharmacology.
Kelly E; Henderson G; Bailey CP
Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
[TBL] [Abstract][Full Text] [Related]
16. Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.
Shen CY; Jiang JG; Yang L; Wang DW; Zhu W
Br J Pharmacol; 2017 Jun; 174(11):1395-1425. PubMed ID: 27659301
[TBL] [Abstract][Full Text] [Related]
17. Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects.
Smeriglio A; Barreca D; Bellocco E; Trombetta D
Br J Pharmacol; 2017 Jun; 174(11):1244-1262. PubMed ID: 27646690
[TBL] [Abstract][Full Text] [Related]
18. Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation.
Donovan MG; Wren SN; Cenker M; Selmin OI; Romagnolo DF
Br J Pharmacol; 2020 Mar; 177(6):1331-1350. PubMed ID: 31691272
[TBL] [Abstract][Full Text] [Related]
19. Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?
Goszcz K; Duthie GG; Stewart D; Leslie SJ; Megson IL
Br J Pharmacol; 2017 Jun; 174(11):1209-1225. PubMed ID: 28071785
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the development and exploitation of new therapeutic options targeting the histaminergic system.
Chazot PL; Tiligada E
Br J Pharmacol; 2020 Feb; 177(3):467-468. PubMed ID: 31994717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
